Product Information
Registration Status: ActiveSIN01361P
ISOPRINOSINE SYRUP 250mg/5ml is approved to be sold in Singapore with effective from 1988-05-18. It is marketed by UNITED ITALIAN TRADING CORPORATION PTE LTD, with the registration number of SIN01361P.
This product contains Methisoprinol 250mg/5ml in the form of SYRUP. It is approved for ORAL use.
This product is manufactured by SWISS PHARMA RESEARCH LABORATORIES INC in PHILIPPINES.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Inosine pranobex (Isoprinosine or Methisoprinol) is a combination of inosine, acetamidobenzoic acid, and dimethylaminoisopropanol used as an antiviral drug.
Indication
Inosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.
Mechanism of Action
Inosine pranobex stimulates cell-mediated immune processes to viral infections.
Pharmacokinetics
- Absorption
- Rapidly absorbed from GIT
- Distribution
- Metabolism
- Elimination
Toxicity
Mouse LD50 (Intravenous ): 1570 mg/kg Muse LD50 (Oral) : 9410mg/kg Mouse LD50 (subcutaneous) ; 2960mg/kg
Active Ingredient/Synonyms
IAD | Inosine acedobene dimepranol | Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3) | Inosiplex | Isoprinosine | Methisoprinol | Inosine pranobex |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.